Loading
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Latest filing published 12 Feb 2026 for Enpro Inc., €118k. Read the official filing
Insider track record
Disclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Adele M. Gulfo: trading record in brief
Adele M. Gulfo (board member) discloses dealings in 3 companies, chiefly Enpro Inc., Myovant Sciences Ltd. and NewAmsterdam Pharma Co N.V. Over a trading history stretching from 15 February 2022 to 12 February 2026, the count stands at 8 filings.
The filings describe grants, exercises and other transfers rather than trades on the open market. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
On 12 February 2026 came the latest disclosure, a share grant for €118k in Enpro Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. For comparison, the SEC allows two business days to file a Form 4. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Adele M. Gulfo
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations8 total
567 shares@ US$246.9150.3% of flowCommon StockSEC:0001225208-26-001823:0
3,400 sharesOrdinary SharesSEC:0001193125-26-009273:0
10,860 sharesOrdinary SharesSEC:0000950170-25-055603:0
803 shares@ US$155.66100.0% of flowCommon StockSEC:0001225208-24-002154:0
3,673 sharesCommon SharesSEC:0001209191-23-017718:0
942 shares@ US$116.6951.4% of flowCommon StockSEC:0001225208-23-002193:0
9,859 shares0Common SharesSEC:0001209191-22-054814:0
1,041 shares@ US$105.6448.6% of flowCommon StockSEC:0001225208-22-002246:0
8 of 8 declarations
